These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 36379926)
1. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma. Nam MH; Stankowska DL; Johnson GA; Nahomi RB; Pantcheva MB; Nagaraj RH Cell Death Dis; 2022 Nov; 13(11):958. PubMed ID: 36379926 [TBL] [Abstract][Full Text] [Related]
2. AAV2-Mediated Expression of HspB1 in RGCs Prevents Somal Damage and Axonal Transport Deficits in a Mouse Model of Ocular Hypertension. Nam MH; Nahomi RB; Pantcheva MB; Dhillon A; Chiodo VA; Smith WC; Nagaraj RH Transl Vis Sci Technol; 2022 Nov; 11(11):8. PubMed ID: 36355386 [TBL] [Abstract][Full Text] [Related]
3. Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma. Stankowska DL; Nam MH; Nahomi RB; Chaphalkar RM; Nandi SK; Fudala R; Krishnamoorthy RR; Nagaraj RH Cell Death Discov; 2019; 5():112. PubMed ID: 31285855 [TBL] [Abstract][Full Text] [Related]
4. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension. Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060 [TBL] [Abstract][Full Text] [Related]
6. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma. Zhu Y; Zhang L; Gidday JM Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension. Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996 [TBL] [Abstract][Full Text] [Related]
8. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma. Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110 [TBL] [Abstract][Full Text] [Related]
9. BDNF Rescues RGCs But Not Intrinsically Photosensitive RGCs in Ocular Hypertensive Albino Rat Retinas. Valiente-Soriano FJ; Nadal-Nicolás FM; Salinas-Navarro M; Jiménez-López M; Bernal-Garro JM; Villegas-Pérez MP; Agudo-Barriuso M; Vidal-Sanz M Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1924-36. PubMed ID: 25722208 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms contributing to inhibition of retinal ganglion cell death by cell permeable peptain-1 under glaucomatous stress. Johnson GA; Kodati B; Nahomi RB; Pham JH; Krishnamoorthy VR; Phillips NR; Krishnamoorthy RR; Nagaraj RH; Stankowska DL Cell Death Discov; 2024 Jun; 10(1):305. PubMed ID: 38942762 [TBL] [Abstract][Full Text] [Related]
11. Mouse model of ocular hypertension with retinal ganglion cell degeneration. Mukai R; Park DH; Okunuki Y; Hasegawa E; Klokman G; Kim CB; Krishnan A; Gregory-Ksander M; Husain D; Miller JW; Connor KM PLoS One; 2019; 14(1):e0208713. PubMed ID: 30640920 [TBL] [Abstract][Full Text] [Related]
12. The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma. Kwong JM; Vo N; Quan A; Nam M; Kyung H; Yu F; Piri N; Caprioli J Exp Eye Res; 2013 Jul; 112():21-8. PubMed ID: 23603611 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of the endothelin A (ET McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604 [TBL] [Abstract][Full Text] [Related]
14. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration. Syc-Mazurek SB; Fernandes KA; Libby RT Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785 [TBL] [Abstract][Full Text] [Related]
15. Oral administration of a dual ET Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR Mol Vis; 2022; 28():165-177. PubMed ID: 36274816 [TBL] [Abstract][Full Text] [Related]
16. Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension. Cao K; Ishida T; Fang Y; Shinohara K; Li X; Nagaoka N; Ohno-Matsui K; Yoshida T Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):13. PubMed ID: 32176263 [TBL] [Abstract][Full Text] [Related]
17. Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure. Yue J; Khan RS; Duong TT; Dine KE; Cui QN; O'Neill N; Aravand P; Liu T; Chaqour B; Shindler KS; Ross AG Neurotherapeutics; 2023 Apr; 20(3):896-907. PubMed ID: 36941497 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma. Phatak NR; Stankowska DL; Krishnamoorthy RR Mol Vis; 2016; 22():1048-61. PubMed ID: 27587945 [TBL] [Abstract][Full Text] [Related]
20. Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location. Feng L; Zhao Y; Yoshida M; Chen H; Yang JF; Kim TS; Cang J; Troy JB; Liu X Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1106-17. PubMed ID: 23322576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]